Release date: 2009-03-30
Researchers at the University of Manitoba in Canada reported at the annual meeting of the American Chemical Society in Salt Lake City, USA on the 22nd that they found that a protein extracted from soybeans helps reduce hypertension in rats and treats chronic kidney disease. .
Rotimi Aluko, who participated in the study, said that he and his colleagues fed experimental mice with chronic kidney disease with hydrolyzed protein extracted from soybeans. After 8 weeks, these rats were compared with normal-fed experimental rats with chronic kidney disease. Compared to the former, the blood pressure is reduced by 20%. Aluko pointed out that this result is significant because most patients with chronic kidney disease die from cardiovascular complications caused by high blood pressure.
Like humans, mice with chronic kidney disease can also reduce their urine output, and the kidneys cannot completely eliminate toxins. A new study by Aluko et al. also showed that after 8 weeks of ingestion of soy hydrolyzed protein, the rats with chronic kidney disease increased their urine output by 30% and returned to normal levels. This indicates that the chronic kidney disease of the experimental mice is also controlled.
However, Aluko stressed that experimental rats and humans can not achieve the purpose of lowering high blood pressure and treating kidney disease by directly eating soy beans, because the hydrolyzed protein contained in soybeans needs to be activated and activated by special enzyme treatment.
Researchers at the University of Manitoba plan to start a human trial of soy hydrolyzed protein in a year. If successful, it is expected to push the soybean hydrolyzed protein product to the pharmaceutical market within 2 to 3 years.
China Medicine 123 Network
Matrine Insecticide,Extract Matrine,Professional Matrine,Cas 519-02-8
Shaanxi The River Pharmaceutical Co., Ltd. , https://www.dahepharma.com